Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linlan Zhou

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Redox Report : Communications in Free Radical Research|March 22, 2026
Ferroptosis inhibition and mitochondrial rescue: a novel mechanism of emodin in rheumatoid arthritisLinlan Zhou, Jun Liu, Jing Ren, et al.
International Journal of Molecular Sciences|May 4, 2026
Emodin Attenuates Rheumatoid Arthritis by Modulating the NF-κB/HIF-1α/VEGF Signaling PathwayDehao Du, Yihang Lou, Linlan Zhou, et al.
Journal of Ethnopharmacology|July 7, 2024
Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney diseaseJun Liu, Jing Ren, Linlan Zhou, et al.
Current Issues in Molecular Biology|July 29, 2025
Investigating the Mechanism of Emodin in Rheumatoid Arthritis Through the HIF-1α/NLRP3 Pathway and Mitochondrial AutophagyDehao Du, Linlan Zhou, Jiayu Tian, et al.
International Immunopharmacology|May 19, 2025
Emodin delays rheumatoid arthritis progression by inhibiting the ROS/TXNIP/NLRP3 signaling pathwayLinlan Zhou, Jun Liu, Kang Yang, et al.
International Immunopharmacology|August 13, 2024
A new strategy for Astragaloside IV in the treatment of diabetic kidney disease: Analyzing the regulation of ferroptosis and mitochondrial function of renal tubular epithelial cellsJun Liu, Kang Yang, Linlan Zhou, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Redox Report : Communications in Free Radical Research|March 22, 2026
Ferroptosis inhibition and mitochondrial rescue: a novel mechanism of emodin in rheumatoid arthritisLinlan Zhou, Jun Liu, Jing Ren, et al.
International Journal of Molecular Sciences|May 4, 2026
Emodin Attenuates Rheumatoid Arthritis by Modulating the NF-κB/HIF-1α/VEGF Signaling PathwayDehao Du, Yihang Lou, Linlan Zhou, et al.
Journal of Ethnopharmacology|July 7, 2024
Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney diseaseJun Liu, Jing Ren, Linlan Zhou, et al.
Current Issues in Molecular Biology|July 29, 2025
Investigating the Mechanism of Emodin in Rheumatoid Arthritis Through the HIF-1α/NLRP3 Pathway and Mitochondrial AutophagyDehao Du, Linlan Zhou, Jiayu Tian, et al.
International Immunopharmacology|May 19, 2025
Emodin delays rheumatoid arthritis progression by inhibiting the ROS/TXNIP/NLRP3 signaling pathwayLinlan Zhou, Jun Liu, Kang Yang, et al.
International Immunopharmacology|August 13, 2024
A new strategy for Astragaloside IV in the treatment of diabetic kidney disease: Analyzing the regulation of ferroptosis and mitochondrial function of renal tubular epithelial cellsJun Liu, Kang Yang, Linlan Zhou, et al.
Pageof 1